Associations Between Cannabis Messaging and Derived Psychoactive Cannabis Product Perceptions, Use, and Use Intentions Among a Sample of US Young Adults.
Cassidy R LoParco, Matthew E Rossheim, Yuxian Cui, Darcey M McCready, Katelyn F Romm, Yan Wang, Y Tony Yang, Patricia A Cavazos-Rehg, Hannah Szlyk, Erin Kasson, Carla J Berg
{"title":"Associations Between Cannabis Messaging and Derived Psychoactive Cannabis Product Perceptions, Use, and Use Intentions Among a Sample of US Young Adults.","authors":"Cassidy R LoParco, Matthew E Rossheim, Yuxian Cui, Darcey M McCready, Katelyn F Romm, Yan Wang, Y Tony Yang, Patricia A Cavazos-Rehg, Hannah Szlyk, Erin Kasson, Carla J Berg","doi":"10.1080/10826084.2025.2530786","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Since the 2018 Agricultural Improvement Act, derived intoxicating cannabis products (DICPs) emerged as largely unregulated products; meanwhile, traditional cannabis use has increased. To inform effective prevention, research is needed to assess differences in motives for using cannabis <i>only</i> versus <i>both</i> cannabis and DICPs, as well as use-related consequences.</p><p><strong>Methods: </strong>We analyzed survey data (June-November 2023) from 4,031 US young adults ages 18-34 (average age = 26.9; 63.9% White; 59.0% female; aiming for ∼50% past-month cannabis use). The analytic sample included participants reporting past-month cannabis use (<i>n</i> = 1,968). Two cross-sectional mediation models were conducted to examine: 1) cannabis use motives (social/cognitive enhancement and coping) in relation to use-related consequences (psychophysiological and sociobehavioral) <i>via</i> use category (cannabis-only vs. cannabis-DICP co-use) and 2) consequences in relation to use category <i>via</i> use motives.</p><p><strong>Results: </strong>Overall, 54.4% reported cannabis-only use and 45.6% reported cannabis-DICP co-use. Greater enhancement and coping motives were associated with cannabis-DICP co-use (vs. cannabis-only use). Regarding Model #1, lower cannabis coping motives and cannabis-DICP use (vs. cannabis-only use) were associated with greater psychophysiological and sociobehavioral consequences, and the associations between coping and enhancement motives and psychophysiological and sociobehavioral consequences were indirectly mediated <i>via</i> cannabis-DICP co-use. For Model #2, lower psychophysiological and greater sociobehavioral consequences were associated with greater coping and enhancement motives, greater sociobehavioral consequences was associated with higher odds of cannabis-DICP co-use (vs. cannabis-only use), and psychophysiological and sociobehavioral consequences were indirectly associated with cannabis-DICP co-use through enhancement and coping motives.</p><p><strong>Conclusions: </strong>Considering the risks associated with cannabis and DICP use, future intervention and prevention efforts should focus on the observed associations to reduce risk.</p>","PeriodicalId":22088,"journal":{"name":"Substance Use & Misuse","volume":" ","pages":"1-9"},"PeriodicalIF":1.7000,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Substance Use & Misuse","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/10826084.2025.2530786","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Since the 2018 Agricultural Improvement Act, derived intoxicating cannabis products (DICPs) emerged as largely unregulated products; meanwhile, traditional cannabis use has increased. To inform effective prevention, research is needed to assess differences in motives for using cannabis only versus both cannabis and DICPs, as well as use-related consequences.
Methods: We analyzed survey data (June-November 2023) from 4,031 US young adults ages 18-34 (average age = 26.9; 63.9% White; 59.0% female; aiming for ∼50% past-month cannabis use). The analytic sample included participants reporting past-month cannabis use (n = 1,968). Two cross-sectional mediation models were conducted to examine: 1) cannabis use motives (social/cognitive enhancement and coping) in relation to use-related consequences (psychophysiological and sociobehavioral) via use category (cannabis-only vs. cannabis-DICP co-use) and 2) consequences in relation to use category via use motives.
Results: Overall, 54.4% reported cannabis-only use and 45.6% reported cannabis-DICP co-use. Greater enhancement and coping motives were associated with cannabis-DICP co-use (vs. cannabis-only use). Regarding Model #1, lower cannabis coping motives and cannabis-DICP use (vs. cannabis-only use) were associated with greater psychophysiological and sociobehavioral consequences, and the associations between coping and enhancement motives and psychophysiological and sociobehavioral consequences were indirectly mediated via cannabis-DICP co-use. For Model #2, lower psychophysiological and greater sociobehavioral consequences were associated with greater coping and enhancement motives, greater sociobehavioral consequences was associated with higher odds of cannabis-DICP co-use (vs. cannabis-only use), and psychophysiological and sociobehavioral consequences were indirectly associated with cannabis-DICP co-use through enhancement and coping motives.
Conclusions: Considering the risks associated with cannabis and DICP use, future intervention and prevention efforts should focus on the observed associations to reduce risk.
期刊介绍:
For over 50 years, Substance Use & Misuse (formerly The International Journal of the Addictions) has provided a unique international multidisciplinary venue for the exchange of original research, theories, policy analyses, and unresolved issues concerning substance use and misuse (licit and illicit drugs, alcohol, nicotine, and eating disorders). Guest editors for special issues devoted to single topics of current concern are invited.
Topics covered include:
Clinical trials and clinical research (treatment and prevention of substance misuse and related infectious diseases)
Epidemiology of substance misuse and related infectious diseases
Social pharmacology
Meta-analyses and systematic reviews
Translation of scientific findings to real world clinical and other settings
Adolescent and student-focused research
State of the art quantitative and qualitative research
Policy analyses
Negative results and intervention failures that are instructive
Validity studies of instruments, scales, and tests that are generalizable
Critiques and essays on unresolved issues
Authors can choose to publish gold open access in this journal.